We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
76
GSK
GSK
$106B
$145M 0.25%
3,026,885
-276,413
-8% -$13.6M
MDT icon
77
Medtronic
MDT
$112B
$144M 0.25%
1,579,997
+30,423
+2% +$2.84M
DD icon
78
DuPont de Nemours
DD
$19.2B
$143M 0.25%
1,057,606
-59,333
-5% -$8.52M
CCL icon
79
Carnival Corporation Ltd
CCL
$39.7B
$143M 0.25%
2,900,827
+70,592
+2% +$4.04M
OXY icon
80
Occidental Petroleum
OXY
$55.9B
$142M 0.25%
2,306,157
-500,045
-18% -$35.1M
TTE icon
81
TotalEnergies
TTE
$190B
$137M 0.24%
241,438,380
-10,085,714
-4% -$6.31M
HON icon
82
Honeywell
HON
$78B
$135M 0.24%
1,087,632
-50,764
-4% -$6.93M
D icon
83
Dominion Energy
D
$59.3B
$132M 0.23%
1,849,750
-44,161
-2% -$3.23M
NVS icon
84
Novartis
NVS
$297B
$130M 0.23%
1,690,117
+46,875
+3% +$3.65M
MCHP icon
85
Microchip Technology
MCHP
$46B
$129M 0.22%
3,583,888
+63,332
+2% +$2.24M
MA icon
86
Mastercard
MA
$493B
$127M 0.22%
671,398
+23,229
+4% +$4.61M
MMM icon
87
3M
MMM
$94.3B
$126M 0.22%
791,717
+13,284
+2% +$2.21M
VEA icon
88
Vanguard FTSE Developed Markets ETF
VEA
$236B
$126M 0.22%
3,390,033
+56,082
+2% +$2.22M
LMT icon
89
Lockheed Martin
LMT
$136B
$126M 0.22%
480,258
-18,535
-4% -$5.62M
FAST icon
90
Fastenal
FAST
$59.5B
$123M 0.21%
9,423,332
-809,616
-8% -$11M
GSLC icon
91
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$123M 0.21%
2,447,812
-90,985
-4% -$4.94M
BIIB icon
92
Biogen
BIIB
$30.7B
$122M 0.21%
406,384
-15,168
-4% -$4.84M
PNC icon
93
PNC Financial Services
PNC
$101B
$121M 0.21%
1,032,214
+224,408
+28% +$28.6M
USB icon
94
US Bancorp
USB
$99.6B
$119M 0.21%
2,600,719
+10,246
+0.4% +$527K
BDX icon
95
Becton Dickinson
BDX
$48.2B
$114M 0.2%
518,113
-3,402
-0.7% -$790K
BCE icon
96
BCE
BCE
$21.2B
$114M 0.2%
2,877,552
-269,373
-9% -$11M
ADSK icon
97
Autodesk
ADSK
$52.6B
$111M 0.19%
863,609
-36,151
-4% -$4.88M
SHM icon
98
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$108M 0.19%
2,252,158
+83,940
+4% +$4M
SO icon
99
Southern Company
SO
$107B
$105M 0.18%
2,398,302
-42,300
-2% -$1.92M
XLV icon
100
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$105M 0.18%
1,212,580
+202,108
+20% +$18.3M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.